UNIGE document Scientific Article - Case report
previous document  unige:25714  next document
add to browser collection

Hypereosinophilia in patients with multiple sclerosis treated with natalizumab

Simon, H-U
Published in Neurology. 2011, vol. 77, no. 16, p. 1561-4
Abstract To report asymptomatic hypereosinophilia as a potential side effect in patients treated with natalizumab, an α-4 integrin blocking agent.
Keywords AdultAntibodies, Monoclonal, Humanized/therapeutic useFemaleHumansHypereosinophilic Syndrome/complications/drug therapyMiddle AgedMultiple Sclerosis/complications/drug therapy
PMID: 21975205
Full text
Article (Published version) (248 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Scléroses en plaques, neuroimmunologie, encéphalite autoimmune expérimentale (843)
La matrice extracellulaire (651)
(ISO format)
ABBAS, Mohamed et al. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. In: Neurology, 2011, vol. 77, n° 16, p. 1561-4. https://archive-ouverte.unige.ch/unige:25714

345 hits

0 download


Deposited on : 2013-01-18

Export document
Format :
Citation style :